Superior Long-term Outcomes After Surgery in Child-pugh Class a Patients with Single Small Hepatocellular Carcinoma Compared to Radiofrequency Ablation
Overview
Authors
Affiliations
Background And Aims: There are insufficient data comparing long-term prognoses after radiofrequency ablation (RFA) and surgery.
Methods: We compared the baseline characteristics and survival rates of patients (single, ≤3 cm, and Child-Pugh class A) treated surgically (n = 215) and with RFA (n = 255) from January 2000 to December 2007 at our institution.
Results: The surgery group was characterized by younger age, higher prevalence of HBsAg, less cirrhosis, and an increased chance of Child-Pugh score of 5 and CLIP score of 1, compared to the RFA group. During the median follow-up period of 42 months (range 1-109), the 3-, 5- and 7-year overall survival rates in the surgery group were 98, 94, and 94%, respectively, which were significantly higher than those in the RFA group (92, 87, and 76%, respectively, P = 0.002). The 3- and 5-year recurrence-free survival rates were 72 and 66%, respectively, in the surgery group, which were significantly higher than those in the RFA group (34 and 24%, respectively, P < 0.001). The superiority of the survival rates in the surgery group persisted in most patients throughout the subgroup analysis, based on the Child-Pugh score and CLIP score. Multivariate analysis showed that age and surgery as a procedure type were the significant predictive factors for both overall survival [HR = 1.04 (CI 1.001-1.08), P = 0.047 for age; HR = 2.97 (CI 1.19-7.45), P = 0.02 for surgery] and recurrence-free survival [HR = 1.02 (CI 1.01-1.04), P = 0.01 for age; HR = 2.44 (CI 1.76-3.37), P < 0.001 for surgery].
Conclusions: The long-term outcome after surgery for Child-Pugh class A and single small HCC is superior to that after RFA.
Kim S, Kim K, Na B, Kim S, Oh R Ann Hepatobiliary Pancreat Surg. 2024; 28(4):397-411.
PMID: 39175140 PMC: 11599817. DOI: 10.14701/ahbps.24-103.
Hu L, Lin J, Wang A, Shi X, Qiao Y World J Surg Oncol. 2024; 22(1):56.
PMID: 38369480 PMC: 10875898. DOI: 10.1186/s12957-024-03330-8.
Wei Q, Xiong S, Luo W, Liang M, Luo B Clin Exp Med. 2024; 24(1):32.
PMID: 38300338 PMC: 10834626. DOI: 10.1007/s10238-023-01285-w.
Wade R, South E, Anwer S, Sharif-Hurst S, Harden M, Fulbright H Health Technol Assess. 2023; 27(29):1-172.
PMID: 38149643 PMC: 11017143. DOI: 10.3310/GK5221.
Wicks J, Dale B, Ruffolo L, Pack L, Dunne R, Laryea M J Clin Med. 2023; 12(15).
PMID: 37568408 PMC: 10419984. DOI: 10.3390/jcm12155006.